Alignment Healthcare (ALHC) president holds 917K shares after 10b5-1 sale

Rhea-AI Filing Summary

Alignment Healthcare, Inc. (ALHC) reported an insider transaction by President Dawn Christine Maroney. On 2026-08-14, she sold 5,000 shares of common stock at $14.00 per share in an open-market or private transaction. After this sale, she directly held 917,313 shares of Alignment Healthcare common stock. The transaction was carried out under a Rule 10b5-1 trading plan adopted on 2026-03-13.

Insider Trade Summary 10b5-1

Net Seller: 5,000 shares

Net Sell 1 txn

Insider Maroney Dawn Christine

Role President

Sold 5,000 shs ($70K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	5,000	$14.00	$70K

Holdings After Transaction: Common Stock — 917,313 shares (Direct)

Footnotes (1)

1. F1. Date of Rule 10b5-1 plan adoption: 03/13/2026

Key Figures

Shares sold: 5,000 shares Sale price per share: $14.00 Shares owned after transaction: 917,313 shares +1 more

4 metrics

Shares sold 5,000 shares Common Stock sale on 2026-08-14

Sale price per share $14.00 Per-share price for 5,000-share sale on 2026-08-14

Shares owned after transaction 917,313 shares Direct holdings of Dawn Christine Maroney following the sale

Rule 10b5-1 plan adoption date 2026-03-13 Adoption date of trading plan covering this sale

Key Terms

Rule 10b5-1 plan, open market or private transaction, Form 4

3 terms

Rule 10b5-1 plan regulatory

"Date of Rule 10b5-1 plan adoption: 03/13/2026"

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

open market or private transaction financial

"Sale in open market or private transaction"

Form 4 regulatory

"This Form 4 reports one insider transaction"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

What insider transaction did ALHC President Dawn Christine Maroney report on this Form 4?

Dawn Christine Maroney reported a sale of 5,000 shares of Alignment Healthcare common stock. The shares were sold on 2026-08-14 as disclosed in the Form 4 insider filing.

At what price were the ALHC shares sold in Dawn Christine Maroney’s Form 4 filing?

The 5,000 Alignment Healthcare (ALHC) shares were sold at $14.00 per share. This price reflects the per-share transaction value reported for the 2026-08-14 insider sale.

How many ALHC shares does Dawn Christine Maroney hold after the reported sale?

After the transaction, Dawn Christine Maroney directly holds 917,313 shares of Alignment Healthcare common stock. This post-transaction ownership figure is reported in the Form 4 as total shares following the sale.

Was the ALHC insider sale by Dawn Christine Maroney under a Rule 10b5-1 trading plan?

Yes. The filing states the transaction was executed under a Rule 10b5-1 plan. A footnote specifies the trading plan adoption date as 2026-03-13 for this reported sale.

How many ALHC insider transactions are reported in this Form 4 for Dawn Christine Maroney?

The Form 4 reports one insider transaction for Dawn Christine Maroney. It is a single sale of 5,000 shares of Alignment Healthcare common stock on 2026-08-14.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/18/2026 - 04:02 PM Accepted by SEC EDGAR 08/18/2026 - 04:01 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Maroney Dawn Christine

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY RD.

SUITE 1600

(Street)

ORANGE CALIFORNIA 92868

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/14/2026		S(1)		5,000	D	$14	917,313	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Date of Rule 10b5-1 plan adoption: 03/13/2026

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Dawn C. Maroney	08/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)